GFM
OLMA icon

GF Fund Management’s Olema Pharmaceuticals OLMA Stock Holding History

GF Fund Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.3K Buy
1,767
+221
+14% +$4.92K ﹤0.01% 469
2025
Q4 		$38.6K Buy
1,546
+69
+5% +$1.23K ﹤0.01% 428
2025
Q3 		$14.5K Buy
1,477
+55
+4% +$330 ﹤0.01% 524
2025
Q2 		$6.06K Hold
1,422
– – ﹤0.01% 616
2025
Q1 		$5.35K Buy
1,422
+219
+18% +$1.1K ﹤0.01% 620
2024
Q4 		$7.01K Buy
+1,203
New +$12K ﹤0.01% 586

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

GF Fund Management's OLMA Position: Q1 2026 in Review

GF Fund Management increased its Olema Pharmaceuticals (OLMA) stake by 14% in Q1 2026, buying an estimated $4.92K and bringing the position to 1,767 shares worth $26.3K. The position accounts for ﹤0.01% of the portfolio, ranked #469.

GF Fund Management first reported a position in OLMA in Q4 2024 and has held it in 6 quarters since. The position peaked at $38.6K in Q4 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • GF Fund Management held 1,767 shares of Olema Pharmaceuticals worth $26.3K as of Q1 2026.
  • GF Fund Management bought 221 Olema Pharmaceuticals shares in Q1 2026, an estimated $4.92K.
  • Olema Pharmaceuticals made up ﹤0.01% of GF Fund Management's portfolio in Q1 2026, its #469 holding.
  • GF Fund Management first reported a position in Olema Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • GF Fund Management's Olema Pharmaceuticals position peaked at $38.6K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.